Sort
48,018 grants matching “immunotherapy”
Lymphoma Studies
$681,876Wyndham H Wilson · Division Of Clinical Sciences - Nci · ZIA · FY2019 · CA
Immune Mechanisms in Ocular Graft versus Host Disease
$681,732Victor L Perez · University Of Miami School Of Medicine · R01 · FY2015 · EY
Project 1: Perturbation of Pre-Existing Immunity to Chronic Viral Infection Through Immunotherapy
$681,634Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2021 · AI
A Novel Intervention Strategy for Stroke with RTL Therapy
$681,615Halina Offner · Virogenomics, Inc. · R42 · FY2012 · NS
Conserved Element DNA Vaccine
$681,593Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Targeting alternative isoform variation for TCR discovery in platinum-resistant ovarian cancer
$681,544Sanaz Memarzadeh · University Of California Los Angeles · R01 · FY2025 · CA
Cytokine-mediated regulation of immunity and microenvironment in colorectal cancer metastasis
$681,537Sergei I Grivennikov · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Cytokine-mediated regulation of immunity and microenvironment in colorectal cancer metastasis
$681,537Sergei I Grivennikov · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Epigenetic Therapy for Thoracic Malignancies
$681,523David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Cytokines and T Cell Development
$681,506Scott Durum · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Neoantigen-specific T cell responses for Fibrolamellar Hepatocellular Carcinoma
$681,501Mark Yarchoan · Johns Hopkins University · R01 · FY2024 · CA
Immunobiology and immunotherapy of pancreatic cancer
$681,452Robert H Vonderheide · University Of Pennsylvania · R01 · FY2016 · CA
Identifying cellular and molecular signatures from distinct T cell receptor clonotypes associated with favorable immune checkpoint inhibitor responses in HNSCCs
$681,410Robert L Ferris · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DE
Developing a Human in Mouse Cancer Model with a Completely Humanized Stroma
$681,408Ronald J Buckanovich · Magee-Women'S Res Inst And Foundation · R01 · FY2017 · CA
Activation of the DNA-PK-dependent antiviral response as a novel cancer immunotherapy
$681,404Daniel B Stetson · University Of Washington · R01 · FY2024 · CA
The Impact of a Changing Health Care Delivery System on the Quality of Oncology Care
$681,389Nancy L Keating · Harvard Medical School · R01 · FY2022 · CA
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB
$681,243Jyothi Rengarajan · Emory University · R01 · FY2020 · AI
Metabolic regulation of immunosuppressive myeloid cells in the tumor microenvironment of pancreatic cancer.
$681,198Yaqing Zhang · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
MATCHMAKERS - Creating and training AI tools for TCR binding prediction and design
$681,176Michael Birnbaum · Massachusetts Institute Of Technology · OT2 · FY2024 · CA
Clinical Trials Engine to Develop an HIV Cure study to test engineered T cells
$681,125Christina M Coughlin · University Of Pennsylvania · U19 · FY2023 · AI
Alpha-Emitter Therapy of Osteosarcoma
$681,116George Sgouros · Johns Hopkins University · R01 · FY2024 · CA
Home-based actigraphy to predict disability progression and enhance clinical trials in multiple sclerosis
$681,094Ellen M. Mowry · Johns Hopkins University · R01 · FY2022 · NR
Development of a novel class of immunotherapeutic antibody for metastatic prostate cancer
$681,039Jennifer D Wu · Cancure, Llc · R44 · FY2020 · CA
Developmental Core
$680,925Elizabeth A Klonoff · San Diego State University · U54 · FY2008 · CA
Selective disruption of histone deacetylase complexes using protein interaction modulators
$680,864Marc Vidal · Dana-Farber Cancer Inst · R01 · FY2022 · CA